Inequalities in health care and its repercussion in bipolar disorder treatment
DOI:
https://doi.org/10.25118/2763-9037.2018.v8.313Keywords:
Bipolar disorder, mortality, cardiovascular diseasesAbstract
Individuals with bipolar disorder (TB) have a higher risk of morbidity and mortality due to general medical illnesses, especially cardiovascular diseases, compared to the general population. Although multiple causes contribute to this outcome, inequalities in access to care and in the type of treatment implemented for general medical conditions are an important contributor. Different countries have sought to alleviate this problem with solutions that include the implementation of integrated care with psychiatrists and general practitioners, improvement of communication strategies and more efficient use of technology
Downloads
Metrics
References
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748-51.
Kapczinski F, Magalhães PV, Balanzá-Martinez V, Dias VV, Frangou S, Gama CS, et al. Staging systems in bipolar disorder: an international society for bipolar disorders task force report. Acta Psychiatr Scand. 2014;130:354-63.
Mansur RB, Brietzke E, McIntyre RS. Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev. 2015;52:89-104.
Nestsiarovich A, Hurwitz NG, Nelson SJ, Crisanti AS, Kerner B, Kuntz MJ, et al. Systemic challenges in bipolar disorder management: a patientcentered approach. Bipolar Disord. 2017;19:676-88.
Mansur RB, Zugman A, Ahmed J, Cha DS, Subramaniapillai M, Lee Y, et al. Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders. Eur Neuropsychopharmacol. 2017;27:1153-62.6. Wang LY, Chiang JH, Chen SF, Shen YC. Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: a nationwide population-based cohort study. J Affect Disord. 2018;227:31-7.
Alageel A, Tomasi J, Tersigni C, Brietzke E, Zuckerman H, Subramaniapillai M, et al. Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:95-101.
Rios AC, Maurya PK, Pedrini M, Zeni-Graiff M, Asevedo E, Mansur RB, et al. Microbiota abnormalities and the therapeutic potential of
probiotics in the treatment of mood disorders. Rev Neurosci. 2017;28:739-49.
McIntyre RS, Mansur RB, Lee Y, Japiassú L, Chen K, Lu R, et al. Adverse effects of obesity on cognitive functions in individuals at ultra high risk for bipolar disorder: results from the global mood and brain science initiative. Bipolar Disord. 2017;19:128-34.
Kessing LV, Vradi E, McIntyre RS, Andersen PK. Causes of decreased life expectancy over the life span in bipolar disorder. J Affect Disord. 2015;180:142-7.
Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013;70:931-9.
Hayes JF, Marston L, Walters K, King MB, Osborn DP. Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014. Br J Psychiatry. 2017;211:175-81.
Schulman-Marcus J, Goyal P, Swaminathan RV, Feldman DN, Wong SC, Singh HS, et al. Comparison of trends in incidence, revascularization, and inhospital mortality in ST-elevation myocardial infarction in patients with versus without severe mental illness. Am J Cardiol. 2016;117: 1405-10.
Czepielewski L, Daruy Filho L, Brietzke E, Grassi-Oliveira R. Bipolar disorder and metabolic syndrome: a systematic review. Rev Bras Psiquiatr. 2013;35:88-93.
Bradford DW, Kim MM, Braxton LE, Marx CE, Butterfield M, Elbogen EB. Access to medical care among persons with psychoti c and major aff ecti ve disorders. Psychiatr Serv. 2008;59:847-52.
Morrato EH, Cuff el B, Newcomer JW, Lombardo I, Kamat S, Barron J. Metabolic risk status and second-generati on anti psychoti c drug selecti on: a retrospecti ve study of commercially insured pati ents. J Clin Psychopharmacol. 2009;29:26-32.
Hippisley-Cox J, Parker C, Coupland C, Vinogradova Y. Inequaliti es in the primary care of pati ents with coronary heart disease and serious mental health problems: a cross-secti onal study. Heart. 2007;93:1256-62.
Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, et al. Low rates of treatment for hypertension, dyslipidemia and
diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006;86:15-22.
De Hert M, Correll CU, Bobes J, CetkovichBakmas M, Cohen D, Asai I, et al. Physical illness in pati ents with severe mental disorders. I.
Prevalence, impact of medicati ons and dispariti es in health care. World Psychiatry. 2011;10:52-77.
Liu J, Brown J, Morton S, Pott er DE, Patt on L, Patel M, et al. Dispariti es in diabetes and hypertension care for individuals with serious mental illness. Am J Manag Care. 2017;23:304-8.
O’Neill EA. The role of diabetes in predicti ng employment status for individuals with bipolar disorder. Soc Work Public Health. 2016;31:646-55.
McNally L, Ratschen E. The delivery of stop smoking support to people with mental health conditi ons: a survey of NHS stop smoking services. BMC Health Serv Res. 2010;10:179.
Tedeschi GJ, Cummins SE, Anderson CM, Anthenelli RM, Zhuang YL, Zhu SH. Smokers with self-reported mental health conditi ons: a case for screening in the context of tobacco cessati on services. PLoS One. 2016;11:e0159127.
Drope J, Liber AC, Cahn Z, Stoklosa M, Kennedy R, Douglas CE, et al. Who’s sti ll smoking? Dispariti es in adult cigarett e smoking prevalence in the United States. CA Cancer J Clin. 2018;68:106-15.
Szatkowski L, McNeill A. The delivery of smoking cessati on interventi ons to primary care pati ents with mental health problems. Addicti on. 2013;108:1487-94.
Morris CD, Waxmonsky JA, May MG, Giese AA. What do persons with mental illnesses need to quit smoking? Mental health consumer and provider perspecti ves. Psychiatr Rehabil J. 2009;32:276-84.
Bodén R, Molin E, Jernberg T, Kieler H, Lindahl B, Sundström J. Higher mortality aft er myocardial infarcti on in pati ents with severe mental illness: a nati onwide cohort study. J Intern Med. 2015;277:727-36.
Kisely S, Campbell LA, Wang Y. Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br J Psychiatry. 2009;195:545-50.
James M, Thomas M, Frolov L, Riano NS, Vitti nghoff E, Schillinger D, et al. Rates of cervical cancer screening among women with severe mental illness in public health system. Psychiatr Serv. 2017;68:839-42.
Cooke BK, Magas LT, Virgo KS, Feinberg B, Adityanjee A, Johnson FE. Appendectomy for appendiciti s in pati ents with schizophrenia. Am J Surg. 2007;193:41-8.
Rodgers M, Dalton J, Harden M, Street A, Parker G, Eastwood A. Integrated care to address the physical health needs of people with severe mental illness: a mapping review of the recent evidence on barriers, facilitators and evaluati ons. Int J Integr Care. 2018;18:9.
McIntyre RS. Overview of managing medical comorbiditi es in pati ents with severe mental illness. J Clin Psychiatry. 2009;70:e17.
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
